Common virus kills triple-negative breast cancer

Share this content:

the ONA take:

A virus that commonly infects humans without causing sickness has been observed destroying triple-negative breast cancer cells and killing tumors grown from these cells in mice. In a study published in the Cancer Biology & Therapy journal, researchers studied the effect of Adeno-associated virus type 2 (AAV2) on human breast cancer cell line-derived tumors in mice and on a cell-line representative of triple-negative breast cancer.

The results were promising: tumor size in mice treated with AAV2 decreased, areas of cell death were visible, and the AAV2-treated mice outlived the control mice and displayed no symptoms of their disease. The cancer cells infected with the AAV2 produced more of the protein Ki-67, stimulating the immune system, and activated caspases, triggering apoptosis (cell death). The researchers feel the next research step would be an analysis of the body-wide effect on mice, which might serve as a better example of possible human end results.

Common virus kills triple-negative breast cancer
Common virus kills triple-negative breast cancer
A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, report researchers. Adeno-associated virus type 2 (AAV2) infects humans but is not known to cause sickness. Signaling pathways involve molecules in a cell that control cell functions—such as cell division—by cooperation.
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs